Table 1 Genotype, functional alteration, and phenotype of variants in ion channel genes in epileptic encephalopathies

From: Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies

Gene

Genotype (variant no.)

Funotype (variant no.)

EE phenotype (case no.)

Previously reported phenotype (inheritance)

Sodium channel

 SCN1A

Missense (42)

GOF (0)

/

GEFS+ (AD mostly)

pLOF (2), LOF (2)

DS (6)

PEFS+ (AD or de novo), DS (de novo mostly)

UD (38)

DS (18), EIMFS (5), LGS (4), uEE (14)

Truncating (26), splice (10)

Destructive (36)

DS (28), LGS (4), EMAS (1), uEE (7)

 SCN2A

Missense (53)

GOF (2)

OS (2), uEE (3)

BFNS (AD), uEE (de novo)

pLOF (0)

/

UD (51)

OS (12), WS (9), EIMFS (1), LGS (1), uEE (39)

Truncating (2)

Destructive (2)

LGS (1), uEE (1)

 SCN8A

Missense (45)

GOF (8)

DS (1), uEE (21)

/

pLOF (1), LOF (1)

uEE (2)

/

UD (35)

DS (2), EIMFS (1), LGS (1), WS (1), uEE (36)

BFIS (AD)

Truncating (1), splice (1)

Destructive (2)

uEE (2)

/

Potassium channel

 KCNA1

Missense (2)

UD (2)

uEE (2)

EA/myokymiaa (AD)

 KCNA2

Missense (12)

GOF (3)

uEE (8)

GE (de novo)

G-LOF (3)

uEE (5)

/

LOF (4)

DS (2), EMAS (1), uEE (4)

FE (de novo), HSPa (AD)

UD (2)

uEE (2)

/

 KCNB1

Missense (9)

LOF (6)

WS (1), uEE (7)

/

UD (3)

uEE (4)

/

Truncating (1)

Destructive (1)

WS (1)

/

 KCNQ2

Missense (64)

GOF (4)

WS (5), EME (1), uEE (3)

/

pLOF (4), LOF (3)

OS (2), WS (2), uEE (9)

BFNS/uEE (AD mostly)

UD (53)

OS (14), WS (7), uEE (41)

BFNS (AD mostly)

Truncating (2)

Destructive (2)

WS (1), uEE (1)

BFNS (AD mostly)

 KCNT1

Missense (29)

GOF (10)

EIMFS (24), WS (2), uEE (3)

NFLE (AD mostly)

UD (19)

EIMFS (13), uEE (6)

/

Calcium channel

 CACNA1A

Missense (5)

UD (5)

EIMFS (1), LGS (1), uEE (5)

EAa (AD), FHMa (AD)

NMDA receptor

 GRIN1

Missense (7)

pLOF (1), LOF (2)

WS (1), uEE (2)

Severe IDa (de novo)

UD (4)

uEE (5)

Severe IDa (de novo)

 GRIN2A

Missense (3)

GOF (1)

uEE (1)

FE (AD)

LOF (1)

LKS (1), uEE (1)

FE (AD or de novo)

UD (1)

uEE (2)

FE (AD or de novo)

Truncating (0)

Destructive (0)

/

FE (AD mostly)

 GRIN2B

Missense (12)

GOF (2)

WS (2)

FE (de novo)

UD (10)

WS (7), LGS (1), uEE (2)

/

Splice (1)

Destructive (1)

uEE (1)

/

 GRIN2D

Missense (1)

GOF (1)

uEE (2)

/

Cyclic nucleotide-gated ion channel

 HCN1

Missense (7)

GOF (3)

uEE (3)

/

LOF (2)

uEE (2)

/

UD (2)

uEE (2)

IGE (unknown)

  1. Variants in GABA-A receptor genes are summarized in Supplementary Table S 8 online, and all known functional alterations in these genes were LOF. Genes with pathogenic potential to be confirmed are not listed here. Details in Supplementary Table S2–4 online
  2. AD autosomal dominant, BFIS benign familial infantile seizures, BFNS benign familial neonatal seizures, DS Dravet syndrome, EA episodic ataxia, EE epileptic encephalopathy, EIMFS epilepsy of infancy with migrating focal seizures, EMAS epilepsy with myoclonic–atonic seizures, EME early myoclonic encephalopathy, FE focal epilepsy, FHM familial hemiplegic migraine, GE generalized epilepsy, GEFS+ generalized epilepsy with febrile seizures plus, G-LOF gain- and loss-of-function, GOF gain of function, HSP hereditary spastic paraplegia, ID intellectual disability, IGE idiopathic generalized epilepsies, LGS Lennox–Gastaut syndrome, LKS Landau–Kleffner syndrome, LOF loss of function, NFLE nocturnal frontal lobe epilepsy, OS Ohtahara syndrome, PEFS+ partial epilepsy with febrile seizures plus, pLOF partial loss of function, UD functional alteration not determined missense, uEE unspecified epileptic encephalopathy, WS West syndrome
  3. aPhenotype with seizures